Related Experiment Videos

ADAR1 and MicroRNA; A Hidden Crosstalk in Cancer

Charles J Cho1, Seung-Jae Myung2, Suhwan Chang3

  • 1Department of Biomedical Sciences, University of Ulsan College of Medicine, Asan Medical Center, Seoul 05505, Korea. formidable1981@gmail.com.

Insights

RNA editing, a process altering nucleotide sequences, is increasingly recognized in cancer evolution. This review explores how Adenosine deaminase acting on RNA (ADAR) enzymes influence cancer development by regulating microRNAs.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Research

Background:

  • Cancer evolution is traditionally linked to genetic/epigenetic changes.
  • RNA editing, a novel nucleotide alteration, is upregulated in cancer.
  • Adenosine deaminase acting on RNA (ADAR) and APOBEC3B are key RNA editing enzymes.

Purpose of the Study:

  • To review the properties of ADAR enzymes, RNA editing, and microRNA processing.
  • To focus on the influence of ADARs on carcinogenesis.
  • To elucidate ADARs' role in regulating microRNA processing and function.

Main Methods:

  • Literature review of ADAR enzymes.
  • Analysis of RNA editing mechanisms (A-to-I, C-to-U).
  • Examination of microRNA processing and target interactions.

Main Results:

  • RNA editing can alter protein coding, RNA stability, splicing, and microRNA interactions.
  • The functional consequences of RNA editing are under active investigation.
  • ADARs play a significant role in microRNA regulation within carcinogenesis.

Conclusions:

  • RNA editing, particularly by ADARs, represents a critical factor in cancer evolution.
  • ADAR-mediated microRNA regulation is a key mechanism influencing carcinogenesis.
  • Further research is needed to fully understand the functional impact of RNA editing in cancer.

Related Concept Videos